Cargando…

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

BACKGROUND: The risk of hepatocellular carcinoma (HCC) increases with increasing level of hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic characteristics of HBV, including HBV genotype and specific genetic mutations, contribute to the risk of HCC. We examined th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hwai-I, Yeh, Shiou-Hwei, Chen, Pei-Jer, Iloeje, Uchenna H., Jen, Chin-Lan, Su, Jun, Wang, Li-Yu, Lu, Sheng-Nan, You, San-Lin, Chen, Ding-Shinn, Liaw, Yun-Fan, Chen, Chien-Jen
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518166/ https://www.ncbi.nlm.nih.gov/pubmed/18695135 http://dx.doi.org/10.1093/jnci/djn243

Ejemplares similares

Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance
por: Wang, Sheng-Han, et al.
Publicado: (2021)

OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci
por: Su, Wen-Hui, et al.
Publicado: (2007)

Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
por: Lin, Yu-Ju, et al.
Publicado: (2013)

Androgen Enhances Aflatoxin-induced Genotoxicity and Inflammation to Liver Cancer in Male Hepatitis B Patients
por: Wang, Sheng-Han, et al.
Publicado: (2022)

Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription
por: Wu, Chia-Hsin, et al.
Publicado: (2014)

Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers
por: Li, Chiao-Ling, et al.
Publicado: (2022)

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
por: Huang, Chung-Feng, et al.
Publicado: (2017)

HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients
por: Chu, Yu-Ju, et al.
Publicado: (2023)

ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers
por: Liu, Wan-Hsin, et al.
Publicado: (2013)

Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients
por: Liu, Jessica, et al.
Publicado: (2017)

Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies
por: Lee, Mei-Hsuan, et al.
Publicado: (2014)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant
por: Wu, Hui-Lin, et al.
Publicado: (2005)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Hong, Chun-Ming, et al.
Publicado: (2021)

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
por: Cheng, Hsiang-Yun, et al.
Publicado: (2014)

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk
por: Lee, Mei-Hsuan, et al.
Publicado: (2015)

Evaluation of the Cost-Effectiveness of Entecavir Versus Lamivudine in Hepatitis BeAg-Positive Chronic Hepatitis B Patients
por: Yuan, Yong, et al.
Publicado: (2008)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient
por: Wang, Jann-Tay, et al.
Publicado: (2020)

Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
por: Su, Tung-Hung, et al.
Publicado: (2013)

Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication
por: Wu, Chia-Hsin, et al.
Publicado: (2009)

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
por: Liu, Chen-Hua, et al.
Publicado: (2020)

Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma
por: Lu, Meng-Chuan, et al.
Publicado: (2023)

Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
por: Wu, Hui-Chen, et al.
Publicado: (2021)

A real-time convective PCR machine in a capillary tube instrumented with a CCD-based fluorometer
por: Hsieh, Yi-Fan, et al.
Publicado: (2013)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
por: Liu, Chun-Jen, et al.
Publicado: (2020)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2014)

Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan
por: Liao, Shu-Fen, et al.
Publicado: (2012)

A Lego(®)-like swappable fluidic module for bio-chem applications
por: Hsieh, Yi-Fan, et al.
Publicado: (2014)

Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study
por: Yeh, Yi-Chun, et al.
Publicado: (2014)

A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements
por: Lin, Yu-Ju, et al.
Publicado: (2018)

Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
por: Li, Yung-Tsung, et al.
Publicado: (2016)

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
por: Abi-Jaoudeh, Nadine, et al.
Publicado: (2021)

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
por: Lee, Mei-Hsuan, et al.
Publicado: (2017)

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Surgical outcomes after instrumented lumbar surgery in patients of eighty years of age and older
por: Liao, Jen-Chung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9v26u408em5k1qqm97hfooriiq